TAL1 and acute lymphoblastic leukemia: While our study demonstrates USP7 haploinsufficiency inhibits E-protein activity in T-ALL cell lines, demonstration of the effect of USP7 haploinsufficiency on accelerating malignant transformation in vivo will require the development of a USP7 haploinsufficiency murine model with TAL1 oncogenic activity.